Poland
· Delayed Price · Currency is PLN Nestmedic Statistics
Total Valuation
Nestmedic has a market cap or net worth of PLN 17.05 million. The enterprise value is 21.83 million.
| Market Cap | 17.05M |
| Enterprise Value | 21.83M |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nestmedic has 32.04 million shares outstanding. The number of shares has increased by 10.64% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 32.04M |
| Shares Change (YoY) | +10.64% |
| Shares Change (QoQ) | +2.88% |
| Owned by Insiders (%) | 24.58% |
| Owned by Institutions (%) | 0.45% |
| Float | 6.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.59 |
| PB Ratio | 6.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.14 |
| EV / Sales | 18.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75, with a Debt / Equity ratio of 1.53.
| Current Ratio | 0.75 |
| Quick Ratio | 0.11 |
| Debt / Equity | 1.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.66 |
Financial Efficiency
Return on equity (ROE) is -133.31% and return on invested capital (ROIC) is -41.37%.
| Return on Equity (ROE) | -133.31% |
| Return on Assets (ROA) | -25.42% |
| Return on Invested Capital (ROIC) | -41.37% |
| Return on Capital Employed (ROCE) | -88.61% |
| Revenue Per Employee | 288,148 |
| Profits Per Employee | -1.32M |
| Employee Count | 4 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.08 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.64% in the last 52 weeks. The beta is 0.14, so Nestmedic's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -51.64% |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 41.66 |
| Average Volume (20 Days) | 4,018 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nestmedic had revenue of PLN 1.15 million and -5.27 million in losses. Loss per share was -0.19.
| Revenue | 1.15M |
| Gross Profit | 838,240 |
| Operating Income | -4.88M |
| Pretax Income | -5.27M |
| Net Income | -5.27M |
| EBITDA | -3.83M |
| EBIT | -4.88M |
| Loss Per Share | -0.19 |
Balance Sheet
The company has 268,700 in cash and 3.90 million in debt, giving a net cash position of -3.63 million or -0.11 per share.
| Cash & Cash Equivalents | 268,700 |
| Total Debt | 3.90M |
| Net Cash | -3.63M |
| Net Cash Per Share | -0.11 |
| Equity (Book Value) | 2.55M |
| Book Value Per Share | 0.08 |
| Working Capital | -1.46M |
Cash Flow
| Operating Cash Flow | -4.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 72.73% |
| Operating Margin | -423.30% |
| Pretax Margin | -457.47% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nestmedic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.64% |
| Shareholder Yield | -10.64% |
| Earnings Yield | -30.93% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Nestmedic has an Altman Z-Score of -3.73. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.73 |
| Piotroski F-Score | n/a |